Author:
Fabbro Doriano,Ruetz Stephan,Buchdunger Elisabeth,Cowan-Jacob Sandra W,Fendrich Gabriele,Liebetanz Janis,Mestan Jürgen,O'Reilly Terence,Traxler Peter,Chaudhuri Bhabatosh,Fretz Heinz,Zimmermann Jürg,Meyer Thomas,Caravatti Giorgio,Furet Pascal,Manley Paul W
Subject
Pharmacology (medical),Pharmacology
Reference123 articles.
1. Recent progress towards the identification of selective inhibitors of serine/threonine protein kinases;Adams;Curr Opin Drug Discov Devel,1999
2. Mice without telomerase: what can they teach us about human cancer?;Artandi;Nat Med,2000
3. Molecular targets for breast cancer therapy and prevention;Bange;Nat Med,2001
4. Roots of clinical resistance to STI-571 cancer therapy;Barthe;Science,2001
5. Oncogenic kinase signalling;Blume-Jensen;Nature,2001
Cited by
298 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME prediction;Bioorganic Chemistry;2024-09
2. Prediction of Protein Targets in Ovarian Cancer Using a Ru-Complex and Carbon Dot Drug Delivery Therapeutic Nanosystems: A Bioinformatics and µ-FTIR Spectroscopy Approach;Pharmaceutics;2024-07-27
3. Development of New N-{4-[(7-Chloro-5-methylpyrrolo[2,1-f] [1,2,4]triazin-4-yl)oxy]-3-fluorophenyl}benzenesulfonamide Analogues: Exploring Anticancer Potential through MerTK Inhibition;Synlett;2024-07-04
4. Benzimidazole-oxindole hybrids as multi-kinase inhibitors targeting melanoma;Bioorganic Chemistry;2024-05
5. Development of 1,5-diarylpyrazoles as EGFR/JNK-2 dual inhibitors: design, synthesis, moleecular docking, and bioactivity evaluation;Bioorganic & Medicinal Chemistry Letters;2024-04